CAREDX, INC. Payments to Acquire Marketable Securities
CAREDX, INC. (CDNA) reported Payments to Acquire Marketable Securities of $39.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-07-30
- CAREDX, INC. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CAREDX, INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $39.85M, a 24.05% decline year-over-year.
- CAREDX, INC. payments to acquire marketable securities for the quarter ending 2025-12-31 was $61.57M, a 260.06% increase year-over-year.
- CAREDX, INC. payments to acquire marketable securities for the quarter ending 2025-09-30 was $17.07M, a 65.84% decline year-over-year.
- CAREDX, INC. payments to acquire marketable securities for fiscal 2025 was $145.93M, a 8.96% decline from fiscal 2024.
- CAREDX, INC. payments to acquire marketable securities for fiscal 2024 was $160.29M, a 20.32% decline from fiscal 2023.
- CAREDX, INC. payments to acquire marketable securities for fiscal 2023 was $201.16M, a 36.17% decline from fiscal 2022.
- CAREDX, INC. payments to acquire marketable securities for fiscal 2022 was $315.14M, a 5629.91% increase from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $39.85M 10-Q · filed 2026-07-30 | $101.42M derived: sum of 3 quarters · filed 2026-07-30 | $118.50M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $39.85M 10-Q · filed 2026-04-28 | $101.42M derived: sum of 2 quarters · filed 2026-04-28 | $118.50M derived: sum of 3 quarters · filed 2026-04-28 | $133.30M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $61.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $78.64M derived: sum of 2 quarters · filed 2026-02-25 | $93.45M derived: sum of 3 quarters · filed 2026-07-30 | $145.93M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $17.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $31.88M derived: sum of 2 quarters · filed 2026-07-30 | $84.35M 10-Q · filed 2025-11-04 | $101.45M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $14.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $67.28M 10-Q · filed 2026-07-30 | $84.38M derived: sum of 3 quarters · filed 2026-07-30 | $134.35M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $52.47M 10-Q · filed 2026-04-28 | $69.57M derived: sum of 2 quarters · filed 2026-04-28 | $119.55M derived: sum of 3 quarters · filed 2026-04-28 | $155.01M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $67.07M derived: sum of 2 quarters · filed 2026-02-25 | $102.54M derived: sum of 3 quarters · filed 2026-02-25 | $160.29M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $49.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $85.44M derived: sum of 2 quarters · filed 2025-11-04 | $143.19M 10-Q · filed 2025-11-04 | $152.22M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $35.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $93.21M 10-Q · filed 2025-08-06 | $102.25M derived: sum of 3 quarters · filed 2026-02-25 | $159.11M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $57.75M 10-Q · filed 2025-04-30 | $66.78M derived: sum of 2 quarters · filed 2026-02-25 | $123.64M derived: sum of 3 quarters · filed 2026-02-25 | $172.60M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $65.89M derived: sum of 2 quarters · filed 2026-02-25 | $114.86M derived: sum of 3 quarters · filed 2026-02-25 | $201.16M 10-K · filed 2026-02-25 | $0.00 10-K · filed 2024-02-28 |
| 2023-09-30 | $56.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $105.82M derived: sum of 2 quarters · filed 2024-11-04 | $192.13M 10-Q · filed 2024-11-04 | $223.83M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $48.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $135.27M 10-Q · filed 2024-07-31 | $166.97M derived: sum of 3 quarters · filed 2025-02-28 | $267.50M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $86.31M 10-Q · filed 2024-05-09 | $118.01M derived: sum of 2 quarters · filed 2025-02-28 | $218.54M derived: sum of 3 quarters · filed 2025-02-28 | $252.93M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $31.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $132.23M derived: sum of 2 quarters · filed 2025-02-28 | $166.62M derived: sum of 3 quarters · filed 2025-02-28 | $315.14M 10-K · filed 2025-02-28 | $0.00 10-K · filed 2023-02-27 |
| 2022-09-30 | $100.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $134.92M derived: sum of 2 quarters · filed 2023-11-08 | $283.44M 10-Q · filed 2023-11-08 | $283.44M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $34.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $182.91M 10-Q · filed 2023-08-08 | $182.91M derived: sum of 3 quarters · filed 2024-02-28 | $182.91M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $148.52M 10-Q · filed 2023-05-10 | $148.52M derived: sum of 2 quarters · filed 2024-02-28 | $148.52M derived: sum of 3 quarters · filed 2024-02-28 | $154.02M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $5.50M derived: sum of 3 quarters · filed 2024-02-28 | $5.50M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.50M derived: sum of 2 quarters · filed 2022-11-03 | $5.50M 10-Q · filed 2022-11-03 | $95.53M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.50M 10-Q · filed 2022-08-04 | $95.53M derived: sum of 3 quarters · filed 2023-02-27 | $95.53M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $90.03M derived: sum of 2 quarters · filed 2023-02-27 | $90.03M derived: sum of 3 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $90.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $90.03M derived: sum of 2 quarters · filed 2023-02-27 | $90.03M 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |